Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Camp4 Therapeutics (CAMP) EBT (2023 - 2025)

Historic EBT for Camp4 Therapeutics (CAMP) over the last 3 years, with Q3 2025 value amounting to -$13.2 million.

  • Camp4 Therapeutics' EBT rose 189.85% to -$13.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$51.6 million, marking a year-over-year decrease of 40.67%. This contributed to the annual value of -$51.8 million for FY2024, which is 507.19% down from last year.
  • Per Camp4 Therapeutics' latest filing, its EBT stood at -$13.2 million for Q3 2025, which was up 189.85% from -$12.6 million recorded in Q2 2025.
  • In the past 5 years, Camp4 Therapeutics' EBT ranged from a high of -$11.7 million in Q3 2023 and a low of -$13.5 million during Q3 2024
  • Moreover, its 3-year median value for EBT was -$12.6 million (2025), whereas its average is -$12.7 million.
  • In the last 5 years, Camp4 Therapeutics' EBT crashed by 1528.73% in 2024 and then surged by 189.85% in 2025.
  • Camp4 Therapeutics' EBT (Quarter) stood at -$13.0 million in 2023, then fell by 2.22% to -$13.3 million in 2024, then increased by 0.38% to -$13.2 million in 2025.
  • Its EBT stands at -$13.2 million for Q3 2025, versus -$12.6 million for Q2 2025 and -$12.5 million for Q1 2025.